Previous Article | Next Article ![]()
Infection and Immunity, December 1999, p. 6611-6618, Vol. 67, No. 12
Chemistry Department, Georgetown University,
Washington, D.C. 20056,1 and Department
of Molecular Pathology, Walter Reed Army Institute of Research,
Washington, D.C. 203072
Received 21 April 1999/Returned for modification 14 June
1999/Accepted 16 August 1999
The superantigen staphylococcal enterotoxin B (SEB) simultaneously
binds both the major histocompatibility complex (MHC) class II receptor
on monocytes and the T-cell receptor (TCR) on T lymphocytes, resulting
in a range of cell responses including induction of tumor necrosis
factor alpha (TNF-
0019-9567/99/$04.00+0
Production of Tumor Necrosis Factor Alpha in Human
T Lymphocytes by Staphylococcal Enterotoxin B Correlates with
Toxin-Induced Proliferation and Is Regulated through Protein
Kinase C

). In this study, we have used mixed cultures of
human peripheral blood monocytes and lymphocytes to investigate
biochemical events controlling SEB induction of TNF-
. TNF-
production induced by SEB in mixed cultures is more closely associated
with T cells than with monocytes: (i) a TCR-binding-site mutant of SEB
(N23F) is less active in TNF-
induction than an MHC class II
receptor-binding-site mutant (F44R), and (ii) flow cytometric analysis
indicated that SEB induced TNF-
production in T cells but not in
monocytes. Pretreatment of cells with inhibitors of signal transduction
pathways was employed to further define events in SEB-induced TNF-
production. Neither protein kinase A inhibitors nor two protein
tyrosine kinase inhibitors altered SEB-induced TNF-
production. In
contrast, SEB induced protein kinase C (PKC) translocation, and
pretreatment of cultures with inhibitors of PKC blocked TNF-
induction. Alteration of levels of diacylglycerol (DAG), an activator
of PKC, by treatment with inhibitors of phospholipase C or DAG kinase
also altered SEB-induced TNF-
production. These data suggest that
PKC activation plays a critical role in SEB-induced TNF-
production
in human T cells.
*
Corresponding author. Mailing address: Department of
Molecular Pathology, Walter Reed Army Institute of Research, Building 503, 503 Robert Grant Rd., Silver Spring, MD 20910. Phone: (301) 319-9997. Fax: (301) 319-7699. E-mail:
marti.jett{at}na.amedd.army.mil.
Present address: R. W. Johnson Pharmaceutical Research
Institute, Spring House, PA 19477.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|